MARKET

OPGN

OPGN

OpGen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.480
-0.090
-3.50%
After Hours: 2.500 +0.02 +0.81% 19:22 04/03 EDT
OPEN
2.550
PREV CLOSE
2.570
HIGH
2.670
LOW
2.480
VOLUME
889.78K
TURNOVER
--
52 WEEK HIGH
15.20
52 WEEK LOW
0.9200
MARKET CAP
29.59M
P/E (TTM)
-0.1577
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average OPGN stock price target is 5.00 with a high estimate of 5.00 and a low estimate of 5.00.

EPS

OPGN News

More
  • Edited Transcript of OPGN earnings conference call or presentation 24-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 1d ago
  • The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
  • Benzinga · 3d ago
  • The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
  • Benzinga · 3d ago
  • OpGen and Curetis Successfully Close their Business Combination Transaction
  • GlobeNewswire · 4d ago

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About OPGN

OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name.
More

Webull offers kinds of OpGen Inc stock information, including NASDAQ:OPGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPGN stock news, and many more online research tools to help you make informed decisions.